Combination treatment approaches and novel therapies for lymphoma

Clin Adv Hematol Oncol. 2007 Aug;5(8 Suppl 12):4-20; quiz 1 p following 20.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antibodies, Anti-Idiotypic / therapeutic use
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bendamustine Hydrochloride
  • Boronic Acids / therapeutic use
  • Bortezomib
  • Cancer Vaccines / immunology
  • Cancer Vaccines / therapeutic use
  • Cytokines / therapeutic use
  • Humans
  • Immunologic Factors / therapeutic use
  • Lymphoma, Non-Hodgkin / drug therapy
  • Lymphoma, Non-Hodgkin / immunology
  • Lymphoma, Non-Hodgkin / therapy*
  • Nitrogen Mustard Compounds / therapeutic use
  • Pyrazines / therapeutic use
  • Rituximab
  • Stem Cell Transplantation

Substances

  • Antibodies, Anti-Idiotypic
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Boronic Acids
  • Cancer Vaccines
  • Cytokines
  • Immunologic Factors
  • Nitrogen Mustard Compounds
  • Pyrazines
  • Rituximab
  • Bortezomib
  • Bendamustine Hydrochloride
  • galiximab